Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Intravenous Cardene(Nicardipine)and Labetalol Use in the Emergency Department

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years of age or older~* Systolic blood pressure ≥180 mm Hg on 2 consecutive readings(10 minutes apart)presenting in the emergency department (ED)~Exclusion Criteria:~* Use of any investigational drug within 1 month prior to emergency department (ED)~* Pregnant or breast-feeding females~* Contraindications or allergy to beta-blockers and calcium channel blockers (see FDA approved labeling for nicardipine intravenous and labetalol)~* Subjects with decompensated congestive heart failure (CHF) or with a known left ventricular ejection fraction (LVEF) \<35%~* History of stroke within 30 days~* Known liver failure~* Suspected myocardial infarction~* Suspected aortic dissection~* Suspected cocaine overdose~* Concurrently receiving other intravenous (I.V.) hypertensive medications

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): nicardipine intravenous
- 2 (Type: ACTIVE_COMPARATOR): Labetalol

Based on this trial design, predict the completion outcome and termination type (if applicable).